RXO (NYSE: RXO) reported Q2 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.04 billion.

For earnings history and earnings-related data on RXO (RXO) click here.